Study of BMS-986168 in Patients With Progressive Supranuclear Palsy
Condition: Progressive Supranuclear Palsy Interventions: Biological: BMS-986168; Biological: Placebo Sponsor: Bristol-Myers Squibb Not yet recruiting - verified February 2017
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials